These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37012546)

  • 41. Assessment of treatment response in non-alcoholic steatohepatitis using advanced magnetic resonance imaging.
    Lin SC; Heba E; Bettencourt R; Lin GY; Valasek MA; Lunde O; Hamilton G; Sirlin CB; Loomba R
    Aliment Pharmacol Ther; 2017 Mar; 45(6):844-854. PubMed ID: 28116801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimization of region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification.
    Hong CW; Wolfson T; Sy EZ; Schlein AN; Hooker JC; Fazeli Dehkordy S; Hamilton G; Reeder SB; Loomba R; Sirlin CB
    J Magn Reson Imaging; 2018 Apr; 47(4):988-994. PubMed ID: 28842937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MRI-determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes.
    Vu KN; Gilbert G; Chalut M; Chagnon M; Chartrand G; Tang A
    J Magn Reson Imaging; 2016 May; 43(5):1090-9. PubMed ID: 26536609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative MRI Assessment of Pancreatic Steatosis Using Proton Density Fat Fraction in Pediatric Obesity.
    Kim J; Albakheet SS; Han K; Yoon H; Lee MJ; Koh H; Kim S; Suh J; Han SJ; Ihn K; Shin HJ
    Korean J Radiol; 2021 Nov; 22(11):1886-1893. PubMed ID: 34269534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differences in multi-echo chemical shift encoded MRI proton density fat fraction estimation based on multifrequency fat peaks selection in non-alcoholic fatty liver disease patients.
    Martí-Aguado D; Alberich-Bayarri Á; Martín-Rodríguez JL; França M; García-Castro F; González-Cantero J; González-Cantero Á; Martí-Bonmatí L
    Clin Radiol; 2020 Nov; 75(11):880.e5-880.e12. PubMed ID: 32888653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
    Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
    World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantification of Liver Fat by MRI-PDFF Imaging in Patients with Suspected Non-alcoholic Fatty Liver Disease and Its Correlation with Metabolic Syndrome, Liver Function Test and Ultrasonography.
    Rodge GA; Goenka MK; Goenka U; Afzalpurkar S; Shah BB
    J Clin Exp Hepatol; 2021; 11(5):586-591. PubMed ID: 34511820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitis.
    Hong CW; Mamidipalli A; Hooker JC; Hamilton G; Wolfson T; Chen DH; Fazeli Dehkordy S; Middleton MS; Reeder SB; Loomba R; Sirlin CB
    J Magn Reson Imaging; 2018 Apr; 47(4):995-1002. PubMed ID: 28851124
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diurnal Variation of Proton Density Fat Fraction in the Liver Using Quantitative Chemical Shift Encoded MRI.
    Colgan TJ; Van Pay AJ; Sharma SD; Mao L; Reeder SB
    J Magn Reson Imaging; 2020 Feb; 51(2):407-414. PubMed ID: 31168893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Accuracy of common proton density fat fraction thresholds for magnitude- and complex-based chemical shift-encoded MRI for assessing hepatic steatosis in patients with obesity.
    Cunha GM; Thai TT; Hamilton G; Covarrubias Y; Schlein A; Middleton MS; Wiens CN; McMillan A; Agni R; Funk LM; Campos GM; Horgan S; Jacobson G; Wolfson T; Gamst A; Schwimmer JB; Reeder SB; Sirlin CB
    Abdom Radiol (NY); 2020 Mar; 45(3):661-671. PubMed ID: 31781899
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease.
    Achmad E; Yokoo T; Hamilton G; Heba ER; Hooker JC; Changchien C; Schroeder M; Wolfson T; Gamst A; Schwimmer JB; Lavine JE; Sirlin CB; Middleton MS
    Abdom Imaging; 2015 Oct; 40(8):3084-90. PubMed ID: 26205992
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of MRI proton density fat fraction in hepatic steatosis: a systematic review and meta-analysis.
    Azizi N; Naghibi H; Shakiba M; Morsali M; Zarei D; Abbastabar H; Ghanaati H
    Eur Radiol; 2024 Sep; ():. PubMed ID: 39254718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiparametric ultrasound imaging for early-stage steatosis: Comparison with magnetic resonance imaging-based proton density fat fraction.
    Baek J; Basavarajappa L; Margolis R; Arthur L; Li J; Hoyt K; Parker KJ
    Med Phys; 2024 Feb; 51(2):1313-1325. PubMed ID: 37503961
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis.
    Caussy C; Alquiraish MH; Nguyen P; Hernandez C; Cepin S; Fortney LE; Ajmera V; Bettencourt R; Collier S; Hooker J; Sy E; Rizo E; Richards L; Sirlin CB; Loomba R
    Hepatology; 2018 Apr; 67(4):1348-1359. PubMed ID: 29108123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children.
    Zand KA; Shah A; Heba E; Wolfson T; Hamilton G; Lam J; Chen J; Hooker JC; Gamst AC; Middleton MS; Schwimmer JB; Sirlin CB
    J Magn Reson Imaging; 2015 Nov; 42(5):1223-32. PubMed ID: 25847512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of Liver Steatosis With a Novel Ultrasound-Based Technique: A Pilot Study Using MRI-Derived Proton Density Fat Fraction as the Gold Standard.
    Ferraioli G; Maiocchi L; Raciti MV; Tinelli C; De Silvestri A; Nichetti M; De Cata P; Rondanelli M; Chiovato L; Calliada F; Filice C
    Clin Transl Gastroenterol; 2019 Oct; 10(10):e00081. PubMed ID: 31609745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective Evaluation of Hepatic Steatosis Using Ultrasound Attenuation Imaging in Patients with Chronic Liver Disease with Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
    Jeon SK; Lee JM; Joo I; Yoon JH; Lee DH; Lee JY; Han JK
    Ultrasound Med Biol; 2019 Jun; 45(6):1407-1416. PubMed ID: 30975533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility of Ultrasound-Guided Attenuation Parameter for Grading Steatosis With Reference to MRI-PDFF in a Large Cohort.
    Imajo K; Toyoda H; Yasuda S; Suzuki Y; Sugimoto K; Kuroda H; Akita T; Tanaka J; Yasui Y; Tamaki N; Kurosaki M; Izumi N; Nakajima A; Kumada T
    Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2533-2541.e7. PubMed ID: 34768008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat with Radiofrequency Ultrasound Data Using One-dimensional Convolutional Neural Networks.
    Han A; Byra M; Heba E; Andre MP; Erdman JW; Loomba R; Sirlin CB; O'Brien WD
    Radiology; 2020 May; 295(2):342-350. PubMed ID: 32096706
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic value of FibroTouch in identifying hepatic steatosis in NAFLD with MRI-PDFF as the reference standard.
    Mu R; Xia YC; Zhu KY; Lu JY; Luo Q; Zhang L; Lin RK; Cai XB; Qu Y; Lu LG
    J Dig Dis; 2023 Dec; 24(12):691-701. PubMed ID: 37994615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.